D. E. Shaw & Co »

Kyverna Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9M 519k 9.40

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Palantir Technologies Cl A Call Option (PLTR)
Tesla Motors (TSLA)
Advanced Micro Devices Put Option (AMD)
Apple Put Option (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology Put Option (MU)
Booking Holdings (BKNG)
Meta Platforms Cl A Call Option (META)
Netflix Put Option (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Texas Instruments Incorporated Call Option (TXN)

View all positions for D. E. Shaw & Co

Top funds holding Kyverna Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
Adage Capital Partners GP
AIGH Capital Management
Insight Holdings
Balyasny Asset Management
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Millennium Management
BlackRock
D. E. Shaw & Co

View all funds holding Kyverna Therapeutics